Eighty-eight potential drugs were considered as candidates for the key genes TNF and IL6, and DALIMUMAB, ETANERCEPT, INFLIXIMAB, PF-04236921, and INSULIN were found to act against both TNF and IL6 and were identified as potentially contributing to the treatment of scleritis. The gene discussed is IL6; the disease is scleritis.